NCT07157579Not yet recruiting
Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
Study of Notch 1 Mutation in Chronic Lymphocytic Leukemia and Non-Hodgkin's Lymphoma Patient
Source: ClinicalTrials.gov · Last updated 5 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
* Detection of Notch1 mutation in BM or peripheral blood of of patients with NHL * Detection of Notch1 mutation in BM or peripheral blood of of patients with chronic lymphocytic leukemia . * Comparison between expression of mutation in patient with CLL and NHL.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 80 (estimated)
- First submitted
- 18 Aug 2025
- Start date
- Sept 2025
- Primary completion date
- Sept 2027
- Lead sponsor
- Sohag University
- NCT number
- NCT07157579
What you commit to
- Study type: Observational
- Planned participants: 80
- From Sept 2025 to the primary completion date, Sept 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Refusal to sign an informed written consent, patient on chemotherapy sion Criteria:
Criteria the registry did not label
- IncluInclusion criteria: approval to sign an informed written consent, patient with NHL and CLL .
Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.